A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Study sponsor: Oculis
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-06-22Actual
Enrollment · participants241Actual
Source updated2025-07-11Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.